author-photo

Paul R. Hutson

University of Wisconsin-Madison

56

Papers

1508

Citations

Citation Trend

Filter By

Papers (45) Sort By

Journal Conference Others

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors.

2020 mAbs
Show All
- Source
- Cite
- Save
Citations (2)
Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis.

2020 Drugs - real world outcomes
- Warren E. Rose
- Paul R. Hutson
Show All
- Source
- Cite
- Save
Citations (3)
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin.

2020 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (3)
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

2020 Psychiatry Research-neuroimaging
Show All
- Source
- Cite
- Save
Citations (33)
High dose psilocybin is associated with positive subjective effects in healthy volunteers

2018 Journal of Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (11)
The Adherence Rate Threshold is Drug Specific

2017 Drugs in R & D
Show All
- Source
- Cite
- Save
Citations (10)
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (71)
Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future

2017 The Journal of Clinical Pharmacology
- Diane R. Mould
- Paul R. Hutson
Show All
- Source
- Cite
- Save
Citations (8)
Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer

2015 Clinical Pharmacokinectics
- Paul R. Hutson
Show All
- Source
- Cite
- Save
Citations (1)